Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selective Oxidation and Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111548341B offers a novel route for lenalidomide key intermediate. Enhanced yield and scalability for pharmaceutical supply chains.
Patent CN114315780B reveals a novel oxidation-reduction route for 4-hydroxymethylcoumarin, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN106977572A reveals a novel two-step synthesis route for lithocholic acid offering high purity and significant supply chain cost reduction advantages.
Patent CN107200763B reveals a novel two-step synthesis for lithocholic acid. This method offers high purity and scalable production for pharmaceutical supply chains.
Patent CN103319560A details a high-yield UDCA synthesis from CDCA using NBS oxidation and Luche reduction, offering cost reduction in API manufacturing and reliable pharmaceutical intermediates supply.